FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:675-679 March 10, 1994 Number 10 Next

	Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background X-linked sideroblastic anemia is usually associated with reduced 5-aminolevulinate synthase activity in erythroid cells, and some cases are responsive to treatment with pyridoxine, the precursor to the cofactor of the enzyme. The recently identified gene for an erythroid-specific 5-aminolevulinate synthase isoenzyme and its localization to the X chromosome make it likely that one or more defects in this gene underlie the anemia.

Methods Using a polymorphic dinucleotide-repeat sequence in the erythroid 5-aminolevulinate synthase gene, we confirmed the linkage of this gene to the disorder in a family with X-linked pyridoxine-responsive sideroblastic anemia. We therefore sought evidence of a nucleotide-sequence abnormality in the erythroid 5-aminolevulinate synthase gene by analyzing enzymatically amplified DNA.

Results DNA-sequencing studies in two affected males and one carrier female in the kindred demonstrated a cytosine-to-guanine change at nucleotide 1215 (in exon 8). This change results in the substitution of serine for threonine at amino acid residue 388, near the lysine that binds the pyridoxal phosphate cofactor. In expression studies, the activity of the mutant enzyme was reduced relative to that of the wild type, and this reduction was comparable to that in erythroid cells of the proband during relapse of the anemia; the enzyme activity expressed in the presence of pyridoxine was comparable to that in the proband's marrow cells during remission. Although the affinity of the mutant enzyme for pyridoxal phosphate was not altered, the mutation appears to introduce a conformational change at the active site of the enzyme.

Conclusions We identified a point mutation resulting in an amino acid change near the pyridoxal phosphate-binding site of the erythroid 5-aminolevulinate synthase isoenzyme as the underlying defect in a kindred with X-linked pyridoxine-responsive sideroblastic anemia.

Source Information

From the Department of Biochemistry, University of Adelaide, Adelaide, Australia (T.C.C., M.J.B., C.S.M., B.K.M.); the Department of Medicine, University of Oklahoma College of Medicine and Veterans Affairs Medical Center, Oklahoma City (S.S.B.); and the Department of Hematology, Austin Hospital, Heidelberg, Victoria, Australia (J.S.W.).

Address reprint requests to Dr. Bottomley at the Veterans Affairs Medical Center, Hematology-Oncology Section, 921 N.E. 13th St., Oklahoma City, OK 73104.

Full Text of this Article

This article has been cited by other articles:

• Nakajima, O., Okano, S., Harada, H., Kusaka, T., Gao, X., Hosoya, T., Suzuki, N., Takahashi, S., Yamamoto, M. (2006). Transgenic rescue of erythroid 5-aminolevulinate synthase-deficient mice results in the formation of ring sideroblasts and siderocytes. GENES CELLS 11: 685-700 [Abstract] [Full Text]  
• Donovan, A., Roy, C. N., Andrews, N. C. (2006). The Ins and Outs of Iron Homeostasis. Physiology 21: 115-123 [Abstract] [Full Text]  
• Bekri, S., May, A., Cotter, P. D., Al-Sabah, A. I., Guo, X., Masters, G. S., Bishop, D. F. (2003). A promoter mutation in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causes X-linked sideroblastic anemia. Blood 102: 698-704 [Abstract] [Full Text]  
• Taketani, S., Kakimoto, K., Ueta, H., Masaki, R., Furukawa, T. (2003). Involvement of ABC7 in the biosynthesis of heme in erythroid cells: interaction of ABC7 with ferrochelatase. Blood 101: 3274-3280 [Abstract] [Full Text]  
• Hofer, T., Wenger, R. H., Kramer, M. F., Ferreira, G. C., Gassmann, M. (2003). Hypoxic up-regulation of erythroid 5-aminolevulinate synthase. Blood 101: 348-350 [Abstract] [Full Text]  
• Cazzola, M., May, A., Bergamaschi, G., Cerani, P., Ferrillo, S., Bishop, D. F. (2002). Absent phenotypic expression of X-linked sideroblastic anemia in one of 2 brothers with a novel ALAS2 mutation. Blood 100: 4236-4238 [Abstract] [Full Text]  
• Ames, B. N, Elson-Schwab, I., Silver, E. A (2002). High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased Km): relevance to genetic disease and polymorphisms. Am. J. Clin. Nutr. 75: 616-658 [Abstract] [Full Text]  
• Liu, J., Killilea, D. W., Ames, B. N. (2002). Age-associated mitochondrial oxidative decay: Improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-L- carnitine and/or R-alpha -lipoic acid. Proc. Natl. Acad. Sci. USA 99: 1876-1881 [Abstract] [Full Text]  
• Roy, C. N., Andrews, N. C. (2001). Recent advances in disorders of iron metabolism: mutations, mechanisms and modifiers. Hum Mol Genet 10: 2181-2186 [Abstract] [Full Text]  
• Cotter, P. D., May, A., Li, L., Al-Sabah, A.I., Fitzsimons, E. J., Cazzola, M., Bishop, D. F. (1999). Four New Mutations in the Erythroid-Specific 5-Aminolevulinate Synthase (ALAS2) Gene Causing X-Linked Sideroblastic Anemia: Increased Pyridoxine Responsiveness After Removal of Iron Overload by Phlebotomy and Coinheritance of Hereditary Hemochromatosis. Blood 93: 1757-1769 [Abstract] [Full Text]  
• Harigae, H., Suwabe, N., Weinstock, P. H., Nagai, M., Fujita, H., Yamamoto, M., Sassa, S. (1998). Deficient Heme and Globin Synthesis in Embryonic Stem Cells Lacking the Erythroid-Specific delta -Aminolevulinate Synthase Gene. Blood 91: 798-805 [Abstract] [Full Text]  
• Gattermann, N., Retzlaff, S., Wang, Y.-L., Hofhaus, G., Heinisch, J., Aul, C., Schneider, W. (1997). Heteroplasmic Point Mutations of Mitochondrial DNA Affecting Subunit I of Cytochrome c Oxidase in Two Patients With Acquired Idiopathic Sideroblastic Anemia. Blood 90: 4961-4972 [Abstract] [Full Text]  
• Surinya, K. H., Cox, T. C., May, B. K. (1997). Transcriptional Regulation of the Human Erythroid 5-Aminolevulinate Synthase Gene. IDENTIFICATION OF PROMOTER ELEMENTS AND ROLE OF REGULATORY PROTEINS. J. Biol. Chem. 272: 26585-26594 [Abstract] [Full Text]  
• Furuyama, K., Fujita, H., Nagai, T., Yomogida, K., Munakata, H., Kondo, M., Kimura, A., Kuramoto, A., Hayashi, N., Yamamoto, M. (1997). Pyridoxine Refractory X-Linked Sideroblastic Anemia Caused by a Point Mutation in the Erythroid 5-Aminolevulinate Synthase Gene. Blood 90: 822-830 [Abstract] [Full Text]  
• Ponka, P (1997). Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. Blood 89: 1-25 [Abstract] [Full Text]  
• Harris, J. W. (1994). X-Linked, Pyridoxine-Responsive Sideroblastic Anemia. NEJM 330: 709-711 [Full Text]